Skip to main content
Caplight Logo









Qynapse

Qynapse

Private
ParisHealthcare & Life Scienceshttps://qynapse.com/

Last Round

Series A

Jun 1, 2021

Total Funding Raised

$6.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Qynapse is a medical technology company that develops and commercializes an AI-powered and proprietary neuroimaging software platform for the diagnosis and monitoring of central nervous system (CNS) disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

neuroimagingmedical AIbrain MRI analysisclinical decision supportCNS disordersvolumetric quantificationclinical trial softwareradiology AIneurodegenerationbiomarker analysismedtechdigital healthAI diagnosticscentral nervous systemSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qynapse Comparables

Compare Qynapse with similar companies based on industry and business-model similarity.

Qynapse comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Darmiyan
86%
Brainreader
86%
In-Med Prognostics
85%

Qynapse Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 1, 2021
M&AOct 13, 2020
SeedMay 2, 2018
SeedJul 1, 2015

Key People

Founding team and executive leadership

Lionel Guérin

Chief Financial Officer

Executive Team

Qynapse Investors

Notable investors and investment history

Qynapse investors
InvestorRounds
AgoranovSeed
GO CapitalSeed
Normandie ParticipationsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 91, 4.14x headcount and 4.9x trailing average.

  • Jun 18, 2026

    Monthly visitors grew 39% MoM, reaching 1.4K.

Qynapse Filings

Explore SEC and related filing metadata, where available.

Qynapse filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Qynapse's valuation, stock price, and market status.

Is Qynapse a public or private company?

Qynapse is a private company.

What is the current stock price of Qynapse?

Qynapse is a private company with no public stock price. No recent secondary market data is available.

How much is Qynapse worth (valuation)?

Valuation information for Qynapse is not publicly available.

Can I buy Qynapse stock?

Qynapse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Qynapse's last funding round?

Qynapse's most recent funding round was Series A on June 1, 2021.

Who are the main investors in Qynapse?

Key investors in Qynapse include Agoranov.

Will Qynapse IPO soon?

No public IPO plans have been announced for Qynapse.

How can I track Qynapse secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qynapse's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range16
Year Founded2015
Last FundingJun 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?